Here are the best stories that came across our desks this past week…
Business group embraces bikes: While Portland’s chamber of commerce dropped off the anti-bike cliff last week, a business association in Vancouver BC has realized it’s much smarter to work with bike advocates.
Driverless cars to the rescue!: Is there anything cars can’t do? The media and corporations want us to think they’ll cure congestion and even help us reach vision zero.
Family 411: Bikabout shared a bunch of family biking equipment tips and online resources nationwide.
Winning over NIMBYs: Listen to their input, don’t blame them, and learn how to mitigate their fears — these are just some of the tips from Vancouver-based planner Brent Toderian for overcoming anti-density voices.
Faster with foreign fecal matter?: Don’t let the “poop doping” click-baitey headline fool you, there is something interesting going on with one woman’s research into the impact of a certain microbiome found in the stool samples of elite bike racers.
Charting cycling’s rise: The lastest article from noted bike researchers John Pucher and Ralph Buehler offers a concise summary of positive trends for cycling in major cities — along with three reasons to be optimistic about the future.
Transpo bill on life-support: Oregon’s big transportation funding package is in “peril” as lawmakers try to cobble together a coalition of competing interest groups it needs to pass.
London watch: We’re watching London closely because their mayor has set out bold policy ideas like road pricing and banning auto parking in new developments en route to a bike/walk/transit mode share goal of 80%.
Bias plays role in street safety: The research from PSU-based transportation scientist Tara Goddard on the role of implicit bias in street safety and road culture is as fascinating as it is important.
What’s up in Forest Park: Portland Monthly published a solid roundup of the changes facing Forest Park right now.
Driving high: The debate over the impact of marijuana use on driving has begun. Reuters has the scoop on two studies with competing findings.